225 Results
Explore NIAID Topics for Small Business Innovation Research Contract Solicitation
Funding News Edition: September 4, 2024
The annual NIH solicitation serves as a vehicle for offerors to propose research projects on a multitude of scientific topics from across NIH. Proposals are due October 18, 2024.

NIH Calls for Implementation Science to Help End HIV in the United States
Funding News Edition: September 4, 2024
Projects should include meaningful engagement with implementing partners such as public health departments, healthcare organizations, and other service providers, as well as community members and people with lived experience.
Accelerate Novel Medical Countermeasures Effective Against Radiation Injuries
Funding News Edition: September 4, 2024
Projects will focus on novel ideas in radiation research, specifically medical countermeasures, biodosimetry, or animal model development to diagnose, mitigate, or treat injuries sustained during a radiation mass casualty incident.
Small Business Research: Priority Funding Topics for 2025
Funding News Edition: August 7, 2024
NIH assembled a list of scientific priorities for small business awards that match the research interests of its institutes and centers, including NIAID.

Understand the Critical Drivers of Tuberculosis Transmission
Funding News Edition: August 7, 2024
Greater knowledge of the interactions and factors driving tuberculosis transmission would allow efficacious approaches for preventing transmission to be developed or improved and adapted for broad scale-up.
Study Immune Responses Triggered by Bioactive Components in Arthropod Saliva
Funding News Edition: August 7, 2024
Apply for funding to research immunologic events in vertebrate hosts that occur at the bite site (skin) and systemically during and after feeding by hematophagous and ectoparasitic arthropods.
Use Collaborative Cross Mouse Model for Immunoregulatory and Infectious Disease Research
Funding News Edition: August 7, 2024
Develop and validate use of Collaborative Cross mouse models to reproduce the impact of host genetic variations on human immune system responses, and screen and evaluate mouse lines for use in specific studies and disease models.
Ease Educational Debt Through Loan Repayment Programs
Funding News Edition: August 7, 2024
To be eligible, you must be a doctoral-level clinician or researcher who’s committed to conducting NIH-qualified clinical research. If NIH approves your application, we will repay up to $50,000 each year toward your qualified educational debt.
Explore NIH-Wide Data on New and Early-Stage Investigators
Funding News Edition: August 7, 2024
NIH and NIAID prioritize support for early-stage investigators as a strategy to sustainably strengthen a robust and diverse workforce.
News Briefs and Worth Repeating
Funding News Edition: August 7, 2024
Now Available: New Career Development Sample Applications; Hurry with Submissions for NIH Entrepreneurship Bootcamp; Distinguish the Priority Areas of NIH’s Institutes, Centers, and Offices
What’s NIH’s Policy on Sharing Model Organisms?
Funding News Edition: August 7, 2024
Investigators must include plans for sharing unique model organisms and related resources in their grant applications or contract proposals. Investigators unable to share model organisms or resources are required to state why sharing is not feasible.
Help Strengthen the Pipeline of Antiviral Drugs for the Next Pandemic
Funding News Edition: July 17, 2024
This opportunity encourages discovery and development of small molecule compounds with activity against viral targets that could be administered orally as monotherapy or in combination with other drugs to treat infections caused by viruses of pandemic potential.
Focus of New Opportunity: Mechanisms of Inducing HIV Immunity in Early Life
Funding News Edition: July 17, 2024
Investigate and advance the mechanistic understanding on how immune ontogeny and functionality in early life could be harnessed in the context of HIV vaccines and broadly neutralizing antibodies to protect against acquisition of HIV infection.
Pursue Epigenetic Treatment Strategies Against HBV in HBV/HIV Co-Infection
Funding News Edition: July 17, 2024
Apply for funding to conduct innovative basic, translational, and clinical research to identify and address epigenetic treatment strategies for achieving hepatitis B virus (HBV) cure in people living with HIV.
Share Your Input on Draft Public Access Policy
Funding News Edition: July 17, 2024
The draft Public Access Policy builds upon NIH’s history of providing public access to scholarly publications resulting from the research it supports and proposes additional steps to accelerate access.
A Window into Participant Inclusion in Clinical Research
Funding News Edition: July 17, 2024
A central goal of NIH policies is to ensure that the demographics of participants in our clinical research will inform clinical practice to benefit people who are affected by the disease or condition under study.
News Briefs and Worth Repeating
Funding News Edition: July 17, 2024
Change in Prior Approval Requirements for SBIR/STTR Recipients to Add a Subaward; Funding for Meetings to Support Data Harmonization of Autoimmune Disease Research
R01 Renewal Applications: Calculate Your Budget Cap
Funding News Edition: July 17, 2024
NIAID caps R01 research project grant renewals at 20 percent above the direct costs of the last competing award period, less the costs of certain items like subawards’ facilities and adminsitrative costs.
Check Whether Your Research Is a Good Fit for ARPA-H
Funding News Edition: July 17, 2024
The Advanced Research Projects Agency for Health (ARPA-H) aims to advance high-potential, high-impact biomedical and health research that cannot be readily accomplished through traditional research or commercial activity.

Contact Us
Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.